Who Paid My Doc
Kimmtrak
Drug Oncology
NDC 80446-401-01
General payments
$1,145,584
Research payments
$7,733,184
Through program year 2025, $1,145,584 in general payments and $7,733,184 in research payments were reported against Kimmtrak (Oncology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
8 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $455,497 | 1,894 |
| 2025 | Research | $4,031,521 | 1,088 |
| 2024 | General | $174,920 | 947 |
| 2024 | Research | $752,341 | 197 |
| 2023 | General | $412,846 | 453 |
| 2023 | Research | $1,206,889 | 351 |
| 2022 | General | $102,321 | 108 |
| 2022 | Research | $1,742,433 | 130 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 45 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 43 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
3,402 general · 1,766 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.